JP2012500194A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500194A5
JP2012500194A5 JP2011522551A JP2011522551A JP2012500194A5 JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5 JP 2011522551 A JP2011522551 A JP 2011522551A JP 2011522551 A JP2011522551 A JP 2011522551A JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5
Authority
JP
Japan
Prior art keywords
polypeptide
protein
peptide
allergen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP5705113B2 (ja
JP2012500194A (ja
Filing date
Publication date
Priority claimed from GB0814986A external-priority patent/GB0814986D0/en
Priority claimed from PCT/GB2008/002781 external-priority patent/WO2009022157A2/en
Priority claimed from GB0815218A external-priority patent/GB0815218D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from EP09251252.4A external-priority patent/EP2153841B2/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Publication of JP2012500194A publication Critical patent/JP2012500194A/ja
Publication of JP2012500194A5 publication Critical patent/JP2012500194A5/ja
Publication of JP5705113B2 publication Critical patent/JP5705113B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522551A 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原 Expired - Fee Related JP5705113B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
GB0814986.6 2008-08-15
GB0814986A GB0814986D0 (en) 2008-08-15 2008-08-15 Peptide for il10 production
GBPCT/GB08/002779 2008-08-15
GBPCT/GB08/002778 2008-08-15
GBPCT/GB08/002780 2008-08-15
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
GBPCT/GB08/002781 2008-08-15
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
GB0815218A GB0815218D0 (en) 2008-08-20 2008-08-20 Ragweed peptides for vaccine
GB0815218.3 2008-08-20
GB0901927.4 2009-02-05
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
EP09251252.4A EP2153841B2 (en) 2008-08-15 2009-05-01 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
EP09251252.4 2009-05-01
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
GB0912578.2 2009-07-20
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production

Publications (3)

Publication Number Publication Date
JP2012500194A JP2012500194A (ja) 2012-01-05
JP2012500194A5 true JP2012500194A5 (enExample) 2012-10-04
JP5705113B2 JP5705113B2 (ja) 2015-04-22

Family

ID=41112622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522551A Expired - Fee Related JP5705113B2 (ja) 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原

Country Status (4)

Country Link
US (2) US8821887B2 (enExample)
EP (1) EP2331124A1 (enExample)
JP (1) JP5705113B2 (enExample)
WO (1) WO2010018384A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2393830T1 (sl) 2009-02-05 2015-04-30 Circassia Limited Travni peptidi za cepivo
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
CN107320734A (zh) 2011-04-29 2017-11-07 西莱克塔生物科技公司 从合成纳米载体中控制释放免疫抑制剂
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
GB201209862D0 (en) 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
NZ707615A (en) 2012-10-30 2019-01-25 Aravax Pty Ltd Novel immunotherapeutic molecules and uses thereof
CN105307641A (zh) 2013-05-03 2016-02-03 西莱克塔生物科技公司 用于降低不期望体液免疫应答的给药组合
WO2015042664A1 (en) 2013-09-25 2015-04-02 Monash University Novel immunotherapeutic composition and uses thereof
CN105848677B (zh) * 2013-12-23 2020-01-31 爱尔开-阿贝优公司 在治疗尘螨过敏症中的肽组合及其用途
EA201790551A1 (ru) 2014-09-07 2017-07-31 Селекта Байосайенсиз, Инк. Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору
KR20200020966A (ko) * 2015-03-30 2020-02-26 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법
EP4599848A3 (en) 2017-03-11 2025-12-03 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US12553041B2 (en) 2019-06-04 2026-02-17 Cartesian Therapeutics Inc. Formulations and doses of pegylated uricase
EP4047007B1 (en) * 2019-10-18 2024-06-05 Pell Bio-Med Technology Co., Ltd. Peptide and use thereof in preparation of drug for treating inflammatory diseases and pain

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776761A (en) * 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
EP0463059B1 (en) 1989-03-17 1998-12-30 Immulogic Pharmaceutical Corporation Allergenic proteins from ragweed and uses therefor
ATE178940T1 (de) * 1990-09-11 1999-04-15 Inst Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
HU220462B1 (hu) 1991-10-16 2002-02-28 Immulogic Pharmaceutical Corp. A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US6441157B1 (en) * 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
FI944697L (fi) 1992-04-09 1994-12-07 Immulogic Pharma Corp Ambrosia artemisiifolian pääallergeenien T-soluepitoopit
JPH09501043A (ja) * 1993-04-14 1997-02-04 イミュロジク ファーマスーティカル コーポレイション Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ（室内塵ダニ）由来の主要アレルゲンのｔ細胞エピトープ
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
JPH09512014A (ja) * 1994-04-14 1997-12-02 イミユロジク・フアーマシユーチカル・コーポレーシヨン ダニアレルギー治療用の医薬ペプチド組成物
US7112333B1 (en) * 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
WO1996013589A1 (en) 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
JP2002500198A (ja) * 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
GB0108752D0 (en) 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
WO2003047618A2 (en) * 2001-12-05 2003-06-12 Circassia Limited Immunotherapeutic methods and systems
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
AU2003228133A1 (en) 2002-04-22 2003-11-03 Umc Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2006132607A1 (en) 2005-06-10 2006-12-14 National University Of Singapore Mutant allergen(s)
US20070092532A1 (en) * 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
DK2119450T3 (da) 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
EP1958645A1 (en) * 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
US20110038881A1 (en) 2007-05-09 2011-02-17 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2153841B2 (en) * 2008-08-15 2015-11-11 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

Similar Documents

Publication Publication Date Title
CN102227214B (zh) 二聚体形成减少的组合物
Rafferty et al. Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the laboratory to patients
US20230073594A1 (en) Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases
ES2484796T3 (es) Compuestos de GLP-1 extendidos
RU2657573C2 (ru) Применение долгодействующих пептидов glp-1
US8580918B2 (en) Peptidic GLP-2 agonists
AU2009248041B2 (en) Long-acting Y2 and/or Y4 receptor agonists
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
JP2010536333A5 (enExample)
US20190070287A1 (en) Tolerance therapeutic for treating polypeptide induced immune activation
JP2013063984A (ja) アシル化ｇｌｐ−１化合物
US20150141336A1 (en) Pancreatic Peptide Compounds and Use
RS58530B1 (sr) Mimetici kalcitonina za lečenje bolesti i poremećaja
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
JP2013519717A5 (enExample)
JP2012516693A5 (enExample)
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
ES2663862T3 (es) Modulación de inmunogenicidad de antígeno mediante la eliminación de epítopos reconocidos por linfocitos NKT
MA32770B1 (fr) Anticorps anti-peptides igf-1/e humain modifie
IL277838B1 (en) Method for cleavage of solid phase-bound peptides from the solid phase
EP4615499A1 (en) Vaccine for treating allergies
FR2744123A1 (fr) Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance
CA2460468A1 (en) Novel polypeptide, dna thereof and use of the same
JP2007512812A (ja) 羊膜由来ペプチドおよびその使用
AU2015227499A1 (en) Compositions with reduced dimer formation